Sales Support:
sales@worldwidemarketreports.com
U.S.:+1 415 871 0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Menu Icon Close Icon

Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

Executive Summary

Azoth Analytics has released a research report titled "Global Seasonal Influenza Vaccine Market (2023 Edition)" which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine -IIV, Live Attenuated Influenza Vaccine - LAIV), Valency (Quadrivalent, Trivalent), Age Group (Pediatrics, Adults, Elderly) and By Distribution Channel (Hospitals, Pharmacies, Government Supply) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Spain, China, Japan, Australia, South Korea). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Seasonal Influenza Vaccine Market is expected to generate USD 9.3 Billion by the end of 2029, up from USD 5.8 Billion in 2022. A favourable growth element for the Global Seasonal Influenza Vaccine market is the changing weather conditions, rapid transmissions of respiratory diseases, increasing awareness, and increasing demand for retail. Influenza is a significant global health concern, causing a considerable burden of illness, hospitalizations, and deaths each year. As per WHO, an estimated 1 Million people worldwide are infected by seasonal influenza every year, out of which an estimated 290,000 - 650,000 deaths occur due to flu each year.

During the forecast period, 2024-2029, Global Seasonal Influenza Vaccines expected to expand at a CAGR of 7.61%. The global seasonal influenza vaccine is driven by increasing awareness about flu prevention, rising healthcare expenditure, and growing government initiatives for immunization programs.

Prevention and control of seasonal influenza are primarily achieved through annual vaccination. The flu vaccine is formulated each year to protect against the most prevalent strains of the virus. There are different types of influenza vaccines available in the market. The most common ones include trivalent vaccines (protect against three flu strains) and quadrivalent vaccines (protect against four flu strains). These vaccines may be administered through injection (inactivated vaccine) or nasal spray (live attenuated vaccine).

Retail pharmacies provide easy access to seasonal influenza vaccines for the general population. With numerous pharmacy locations in communities, people can conveniently receive their vaccinations without the need for appointments or visits to healthcare facilities, which may be more time-consuming and less accessible.

Leveraging digital technologies and tracking systems in the seasonal influenza vaccine market offers opportunities to improve vaccine distribution, enhance vaccination campaigns, ensure vaccine safety, and enable data-driven decision-making. By harnessing the power of digital solutions, stakeholders can optimize vaccine delivery, increase vaccine uptake, and ultimately contribute to better influenza prevention and control efforts.



Scope of the Report:

• The report analyses the Seasonal Influenza Vaccine Market by Value (USD Million).

• The report presents the analysis of Seasonal Influenza Vaccine Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Seasonal Influenza Vaccine Market by Vaccine Type (Inactivated Influenza Vaccine (IIV), Live Attenuated Influenza Vaccine (LAIV)).

• The report analyses the Seasonal Influenza Vaccine Market by Valency (Quadrivalent, Trivalent).

• The report analyses the Seasonal Influenza Vaccine Market by Age Group (Pediatrics, Adults, Elderly).

• The report analyses the Seasonal Influenza Vaccine Market by Distribution Channel (Hospitals, Pharmacies, Government Supply).

• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.

• Also, the major opportunities, trends, drivers and challenges of the industry has been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include CSL Seqirus, GlaxoSmithKline, Sanofi, AstraZeneca, Abbott Laboratories, Viatris, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, and Dalian Aleph Biomedical.

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology

2. Strategic Recommendations

2.1 Leveraging digital technologies and tracking systems

2.2 Improved vaccine distribution and access

3. Global Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

3.1 Impact Analysis of Macro Economic Factors on Seasonal Influenza Vaccine Market

3.2 Prequalified Seasonal Influenza Vaccine Worldwide

3.3 Influenza Vaccination Rates

3.4 Quadrivalent Influenza Vaccine Composition

3.5 Average Price Analysis

3.6 Global Seasonal Influenza Vaccine Market: Dashboard

3.7 Global Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

3.8 Global Seasonal Influenza Vaccine Market: Market Production Volume and CAGR, 2019-2029 (in Billion Doses)

3.9 Degree of Impact of Covid 19 on Influenza Vaccine Market

3.10 Global Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

3.10.1 Global Seasonal Influenza Vaccine Market, By Vaccine Type Overview

3.10.2 Global Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

3.10.3 Global Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

3.11 Global Seasonal Influenza Vaccine Market Segmentation : By Valency

3.11.1 Global Seasonal Influenza Vaccine Market, By Valency Overview

3.11.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

3.11.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

3.12 Global Seasonal Influenza Vaccine Market Segmentation : By Age Group

3.12.1 Global Seasonal Influenza Vaccine Market, By Age Group Overview

3.12.2 Global Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

3.12.3 Global Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

3.12.4 Global Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

3.13 Global Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

3.13.1 Global Seasonal Influenza Vaccine Market, By Distribution Channel Overview

3.13.2 Global Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

3.13.3 Global Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

3.13.4 Global Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

4. Global Seasonal Influenza Vaccine Market, Regional Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot

5. Americas Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

5.1 Americas Seasonal Influenza Vaccine Market: Snapshot

5.2 Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.3 Americas Seasonal Influenza Vaccine Market: Key Factors

5.4 Americas Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

5.4.1 Americas Seasonal Influenza Vaccine Market, By Vaccine Type Overview

5.4.2 Americas Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

5.4.3 Americas Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

5.5 Americas Seasonal Influenza Vaccine Market Segmentation : By Valency

5.5.1 Americas Seasonal Influenza Vaccine Market, By Valency Overview

5.5.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

5.5.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

5.6 Americas Seasonal Influenza Vaccine Market Segmentation : By Age Group

5.6.1 Americas Seasonal Influenza Vaccine Market, By Age Group Overview

5.6.2 Americas Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

5.6.3 Americas Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

5.6.4 Americas Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

5.7 Americas Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

5.7.1 Americas Seasonal Influenza Vaccine Market, By Distribution Channel Overview

5.7.2 Americas Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

5.7.3 Americas Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

5.7.4 Americas Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

5.8 Americas Seasonal Influenza Vaccine Market Segmentation : By Country

5.8.1 United States Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.1.1 United States Seasonal Influenza Vaccine Market, By Vaccine Type

5.8.1.2 United States Seasonal Influenza Vaccine Market, By Valency

5.8.1.3 United States Seasonal Influenza Vaccine Market, By Age Group

5.8.1.4 United States Seasonal Influenza Vaccine Market, By Distribution Channel

5.8.2 Canada Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.2.1 Canada Seasonal Influenza Vaccine Market, By Vaccine Type

5.8.2.2 Canada Seasonal Influenza Vaccine Market, By Valency

5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Age Group

5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Distribution Channel

5.8.3 Rest of Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.3.1 Rest of Americas Seasonal Influenza Vaccine Market, By Vaccine Type

5.8.3.2 Rest of Americas Seasonal Influenza Vaccine Market, By Valency

5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Age Group

5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Distribution Channel

6. Europe Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot

6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.3 Europe Seasonal Influenza Vaccine Market: Key Factors

6.4 Europe Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Vaccine Overview

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)

6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

6.5 Europe Seasonal Influenza Vaccine Market Segmentation : By Valency

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Valency Overview

6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.6 Europe Seasonal Influenza Vaccine Market Segmentation : By Age Group

6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview

6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

6.7 Europe Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot

6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.3 Europe Seasonal Influenza Vaccine Market: Key Factors

6.4 Europe Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Vaccine Overview

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)

6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

6.5 Europe Seasonal Influenza Vaccine Market Segmentation : By Valency

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Valency Overview

6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.6 Europe Seasonal Influenza Vaccine Market Segmentation : By Age Group

6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview

6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

6.7 Europe Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

6.7.1 Europe Seasonal Influenza Vaccine Market, By Distribution Channel Overview

6.7.2 Europe Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

6.7.3 Europe Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

6.7.4 Europe Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

6.8 Europe Seasonal Influenza Vaccine Market Segmentation : By Country

6.8.1 Germany Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.1.1 Germany Seasonal Influenza Vaccine Market, By Vaccine Type

6.8.1.2 Germany Seasonal Influenza Vaccine Market, By Valency

6.8.1.3 Germany Seasonal Influenza Vaccine Market, By Age Group

6.8.1.4 Germany Seasonal Influenza Vaccine Market, By Distribution Channel

6.8.2 United Kingdom Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.2.1 United Kingdom Seasonal Influenza Vaccine Market, By Vaccine Type

6.8.2.2 United Kingdom Seasonal Influenza Vaccine Market, By Valency

6.8.2.3 United Kingdom Seasonal Influenza Vaccine Market, By Age Group

6.8.2.4 United Kingdom Seasonal Influenza Vaccine Market, By Distribution Channel

6.9.3 France Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.9.3.1 France Seasonal Influenza Vaccine Market, By Vaccine Type

6.9.3.2 France Seasonal Influenza Vaccine Market, By Valency

6.9.3.3 France Seasonal Influenza Vaccine Market, By Age Group

6.9.3.4 France Seasonal Influenza Vaccine Market, By Distribution Channel

6.9.4 Spain Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.9.4.1 Spain Seasonal Influenza Vaccine Market, By Vaccine Type

6.9.4.2 Spain Seasonal Influenza Vaccine Market, By Valency

6.9.4.3 Spain Seasonal Influenza Vaccine Market, By Age Group

6.9.4.4 Spain Seasonal Influenza Vaccine Market, By Distribution Channel

6.9.5 Rest of Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.9.5.1 Rest of Europe Seasonal Influenza Vaccine Market, By Vaccine Type

6.9.5.2 Rest of Europe Seasonal Influenza Vaccine Market, By Valency

6.9.5.3 Rest of Europe Seasonal Influenza Vaccine Market, By Age Group

6.9.5.4 Rest of Europe Seasonal Influenza Vaccine Market, By Distribution Channel

7. Asia Pacific Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

7.1 Asia Pacific Seasonal Influenza Vaccine Market: Snapshot

7.2 Asia Pacific Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.3 Asia Pacific Seasonal Influenza Vaccine Market: Key Factors

7.4 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

7.4.1 Asia Pacific Seasonal Influenza Vaccine Market, By Vaccine Type Overview

7.4.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

7.4.3 Asia Pacific Seasonal Influenza Vaccine Market Size, Live Attenuated Influenza Vaccine (LIIV) Museum, By Value, 2019H-2029F (USD Million & CAGR)

7.5 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Valency

7.5.1 Asia Pacific Seasonal Influenza Vaccine Market, By Valency Overview

7.5.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

7.5.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

7.6 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Age Group

7.6.1 Asia Pacific Seasonal Influenza Vaccine Market, By Age Group Overview

7.6.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

7.6.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

7.6.4 Asia Pacific Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

7.7 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

7.7.1 Asia Pacific Seasonal Influenza Vaccine Market, By Distribution Channel Overview

7.7.2 Asia Pacific Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

7.7.3 Asia Pacific Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

7.7.4 Asia Pacific Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

7.8 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Country

7.8.1 China Seasonal Influenza Vaccine Market Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.1.1 China Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.1.2 China Seasonal Influenza Vaccine Market, By Valency

7.8.1.3 China Seasonal Influenza Vaccine Market, By Age Group

7.8.1.4 China Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.2 Japan Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.2.1 Japan Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.2.2 Japan Seasonal Influenza Vaccine Market, By Valency

7.8.2.3 Japan Seasonal Influenza Vaccine Market, By Age Group

7.8.1.4 Japan Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.3 Australia Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.3.1 Australia Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.3.2 Australia Seasonal Influenza Vaccine Market, By Valency

7.8.3.3 Australia Seasonal Influenza Vaccine Market, By Age Group

7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.4 South Korea Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.3.1 South Korea Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.3.2 South Korea Seasonal Influenza Vaccine Market, By Valency

7.8.3.3 South Korea Seasonal Influenza Vaccine Market, By Age Group

7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.5 Rest of APAC Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.5.1 Rest of APAC Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.5.2 Rest of APAC Seasonal Influenza Vaccine Market, By Valency

7.8.5.3 Rest of APAC Seasonal Influenza Vaccine Market, By Age Group

7.8.5.4 Rest of APAC Seasonal Influenza Vaccine Market, By Distribution Channel

8. Middle East & Africa Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

8.1 Middle East & Africa Seasonal Influenza Vaccine Market: Snapshot

8.2 Middle East & Africa Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

8.3 Middle East & Africa Seasonal Influenza Vaccine Market: Key Factors

8.4 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

8.4.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Vaccine Type Overview

8.4.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

8.4.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

8.5 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Valency

8.5.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Valency Overview

8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

8.6 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Age Group

8.6.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Age Group Overview

8.6.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

8.7 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

8.7.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Distribution Channel Overview

8.7.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

8.7.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

8.7.4 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Global Seasonal Influenza Vaccine Market

9.2 Drivers

9.3 Restraints

9.4 Trends

10. Industry Ecosystem Analysis

10.1 Macro-Economic Factor Assessment

10.2 Porter Analysis

11. Competitive Positioning

11.1 Recommended Seasonal Influenza Vaccines for Different Age Groups

11.2 Market Share of Prominent Companies

11.3 Company Profiling

11.3.1 CSL Seqirus

11.3.2 GlaxoSmithKline

11.3.3 Sanofi

11.3.4 AstraZeneca PLC

11.3.5 Abbott Laboratories

11.3.6 Viatris

11.3.7 Sinovac Biotech

11.3.8 Serum Institute of India

11.3.9 Daiichi Sankyo

11.3.10 Dalian Aleph Biomedical

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, D...
View More
Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opp...
View More
Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Op...
View More
Asia Pacific Preventive Vaccines Market 2022-2032 By Vaccine Type, Disease, Administration, Pat...
View More
Europe Preventive Vaccines Market 2022-2032 By Vaccine Type, Disease, Administration, Patient, ...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S.:+1 415 871 0703

phoneiconUK :+44-203-289-4040

phoneiconJapan :+81-50-5539-1737

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved